Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-Months vs 9-Months ATT for Tubercular Posterior Uveitis
NCT06613919Phase 4Completed
- Sponsor
- L V Prasad Eye Institute
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Countries
- 3
01
Overview
Phase 4, randomised, single-blind trial in tuberculous uveitis (OTB) (2 arms), sponsored by L V Prasad Eye Institute. Primary endpoint: Non-recurrence of inflammation. Started Jan 2020; status: completed.
02
Conditions
tuberculous uveitis (OTB)
Beyond the preview
Go deeper on NCT06613919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06613919.